matuzumab: Clinical Trials

3 trials of matuzumab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow matuzumab: new trials by email Literature Review of matuzumab trials Research Report on matuzumab

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer
Matuzumab, Epirubicin, Cisplatin - Esophageal Cancer, Gastric Cancer
Phase 2CompletedMerck KGaA, Darmstadt, Germany722005-08-312018-11-02
Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer
Pemetrexed, Matuzumab - Lung Cancer, Non Small Cell Lung Carcinoma
Phase 2CompletedEMD Serono1502005-05-312018-04-06
A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer
EMD 72000 - Ovarian Cancer
Phase 2CompletedEMD Serono382003-04-012017-01-20

Conditions studied

Adenocarcinoma (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Esophageal Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Stomach Neoplasms (1)

Sponsors

EMD Serono (2)  ·  Merck KGaA, Darmstadt, Germany (1)

Countries

Germany (2)  ·  United States (2)  ·  Austria (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Results publications

PMID 17126894, PMID 20497967, PMID 20978446

NIH funding

2005 (1)